PNR (PNR)

$13.8B
Market Cap
21.6
P/E Ratio
1.21
Beta
1.22%
Dividend Yield
Piotroski 7/9Altman Z 4.4 SafeBeneish M -2.44 CleanROIC−WACC -0.4%

Quantitative Summary

Deterministic

Financial health metrics are strong: Piotroski 7/9, Altman Z 4.4 (above 3.0 safe zone threshold).

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation efficiency and earnings quality metrics present a compelling dichotomy between operational leverage and growth trajectory. The company sustains an ROIC of 11.0%, indicating that it generates returns exceeding the cost of equity, though the modest revenue expansion of 2.3% suggests limited top-line scalability at this juncture. Earnings power is primarily driven by a robust net margin of 15.7% rather than asset turnover or leverage; however, the DuPont decomposition reveals an Equity Multiplier of 1.78x that artificially inflates the reported ROE to 16.9%. Fundamental integrity checks remain strong with a Piotroski F-Score of 7/9 and a Beneish M-Score of -2.44, signaling low earnings manipulation risk despite the reliance on leverage to boost returns per share.

Valuation multiples currently sit at 21.6x trailing earnings, which requires context against historical ranges and sector peers to determine if the premium is justified by future cash flow expectations. A discounted cash flow analysis implies a fair value of $123; comparing this intrinsic estimate directly against current market pricing reveals whether the stock is trading above or below its calculated economic worth. The market appears to be pricing in specific growth assumptions that may not align with the observed 2.3% revenue expansion, creating potential divergence between implied forward rates and realized fundamentals unless margin expansion accelerates significantly.

Insider flow data over the last ninety days indicates $1,370,152 net selling, introducing a risk factor delta that warrants scrutiny regarding management's view on near-term prospects or capital return strategies. While the Fama-French alpha is not explicitly provided in the dataset, the combination of strong fundamental scores and insider outflows suggests investors must weigh the quality of earnings generation against potential leadership caution before forming conclusions on downside protection versus upside catalysts.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →9.4%11.4%13.4%
2%$148$112$88
3%$169$123$95
4%$197$138$104

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=11.4%, terminal growth 3%. Fair value $123 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

7/9
Piotroski F-Score
Strong — high operational efficiency and profitability signals
4.4
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.44
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

40.5%
Gross Margin
15.7%
Net Margin
11.0%
ROIC
11.4%
WACC
ROIC − WACC Spread: -0.4%— Negative spread.
+2.3%
Revenue Growth (YoY)
+4.5%
Earnings Growth (YoY)
746.0M
Free Cash Flow
22%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

15.7%
Net Profit Margin
NI ÷ Revenue
×
0.61x
Asset Turnover
Revenue ÷ Assets
×
1.78x
Equity Multiplier
Assets ÷ Equity
=
16.9%
Return on Equity
✅ ROE driven primarily by strong profit margins — a sign of pricing power.

Balance Sheet Health

0.78x
Debt / Equity
1.61x
Current Ratio
11.9x
Interest Coverage
1.6x
Net Debt / EBITDA
4.85%
FCF Yield
943.6M
EBITDA

Insider Activity (Last 90 Days)

Net Insider Flow
-$1M
Net Selling
0
Buy Transactions
2
Sale Transactions
2026-03-02HAUSMANN HEATHER M.Grant1,529 shares
2026-03-02BRAZIS NICHOLAS J.Grant3,185 shares
2026-02-25ROLCHIGO PHILIP MSold 2/8 qtrsGrant$212,646
2026-02-25ROLCHIGO PHILIP MSold 2/8 qtrsSale$670,207
2026-02-23FISHMAN ROBERT PSold 1/8 qtrsGrant28,586 shares

Open-market buys vs sells by company insiders. Source: yfinance.

Earnings Surprise History

Q4
✓ Beat
Est: $1.01
Act: $1.11
+9.7%
Q3
✓ Beat
Est: $1.34
Act: $1.39
+4.0%
Q2
✓ Beat
Est: $1.18
Act: $1.24
+5.0%
Q1
✓ Beat
Est: $1.16
Act: $1.18
+1.8%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

14.5
Forward P/E
PEG Ratio
3.58
Price/Book
2M
Avg Volume
$113.95
52W High
$74.25
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$1.2B
Tracked Passive Exposure
8
ETFs Holding PNR
0.04%
Avg Weight in ETFs
$2.7T
Total ETF AUM

When investors buy or sell ETFs like SDY or VBR, the fund manager is mechanically forced to buy or sell PNR shares regardless of PNR's individual fundamentals. We estimate $1.2B of passive capital is structurally linked to PNR through 8 tracked ETFs. Index rebalances and ETF creation/redemption cycles can create noticeable volume spikes unrelated to company news.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in PNR to visualize passive redemption contagion across ETFs and collateral stocks.

PNR Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
PNREpicenterVOOETFSPYETFVBETFCATLow RiskGELow RiskCATLow RiskGEVLow RiskRTXMed Risk
PNR Price Drop (%)0

If PNR (PNR) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies CATERPILLAR INC (CAT) as the most exposed collateral stock, sharing 2 ETFs with PNR. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 17 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

PNR Ownership Dynamics

Ticker
PNR

Float lock-up computed from 19 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

PNR Capital Efficiency

How efficiently does PNR convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$746M
EBITDA
$944M
FCF Conversion
79%
Reinvestment Rate
21%
79% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
11.0%
ROIC − WACC Spread
-0.4%

PNR converts 79% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. However, the ROIC-WACC spread is negative (-0.4%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-14518$73.63$38,140.34
2026-05-137,581$75.26$570,546.06
2026-05-041,170$79.10$92,547
2026-05-0181$80.71$6,537.51
2026-04-293$82.86$248.58
2026-04-281,150$92.27$106,110.5
2026-04-2278$89.99$7,019.22
2026-04-1718,288$88.74$1.6M
2026-04-16243$88.35$21,469.05
2026-04-15331$90.81$30,058.11
2026-04-14456$91.20$41,587.2
2026-04-1059$90.46$5,337.14
2026-03-2716$85.93$1,374.88
2026-03-2613,373$87.61$1.2M
2026-03-2516$87.58$1,401.28
2026-03-241,185$88.44$104,801.4
2026-03-234$86.49$345.96
2026-03-195$88.27$441.35
2026-03-06285$95.97$27,351.45
2026-03-05285$96.93$27,625.05
2026-02-12148$100.52$14,876.96
2026-02-04813$94.79$77,064.27
2026-01-277,122$108.02$769,318.44
2026-01-231$108.14$108.14
2026-01-2210$107.15$1,071.5
2026-01-09535$103.06$55,137.1
2026-01-028,487$104.14$883,836.18
2025-12-3135$105.78$3,702.3
2025-12-227,658$103.87$795,436.46
2025-12-106$101.86$611.16

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare PNR to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.